lincomycin has been researched along with cefoxitin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gundert-Remy, U | 1 |
| Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
| Back, DJ; Breckenbridge, AM; Cross, KJ; Orme, ML; Thomas, E | 1 |
| Ichimaru, M; Yamaguchi, H | 1 |
| Avila-Campos, MJ; Carvalho, MA; Zelante, F | 1 |
| Cho, BK; Lee, DH; Park, JC; Park, YH; Suh, H; Sung, HJ | 1 |
1 review(s) available for lincomycin and cefoxitin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for lincomycin and cefoxitin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
[Pharmacology of anaerobically active substances].
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria, Anaerobic; Bacterial Infections; Cefoxitin; Clindamycin; Humans; Lincomycin; Mezlocillin; Penicillin G | 1986 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
An antibiotic interaction with ethinyloestradiol in the rat and rabbit.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bile; Cefoxitin; Drug Interactions; Ethinyl Estradiol; Female; Intestines; Kinetics; Lincomycin; Male; Neomycin; Rabbits; Rats; Rats, Inbred Strains; Species Specificity | 1982 |
[Treatment of bacterial infection in acute leukemia, quadruple chemotherapy using CFX, AMK, TIPC and LCM (author's transl)].
Topics: Acute Disease; Adult; Amikacin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Lincomycin; Middle Aged; Penicillins; Ticarcillin | 1980 |
Distribution of biotypes and antimicrobial susceptibility of Actinobacillus actinomycetemcomitans.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Antitrichomonal Agents; Bacterial Typing Techniques; Cefoxitin; Cephamycins; Clindamycin; Dental Plaque; Drug Resistance, Microbial; Erythromycin; Female; Humans; Imipenem; Lincomycin; Male; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Penicillins; Periodontitis; Tetracycline; Thienamycins | 1995 |
Antibacterial effect of antibiotic solution on cellular viability in canine veins.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Dogs; Endothelium, Vascular; Lincomycin; Polymyxin B; Solutions; Statistics, Nonparametric; Vancomycin; Veins | 2001 |